HYUNDAI PHARMACEUTICAL CO., LTD Logo

HYUNDAI PHARMACEUTICAL CO., LTD

004310 | KO

Overview

Corporate Details

ISIN(s):
KR7004310009
LEI:
Country:
South Korea
Address:
충청남도 천안시 동남구 풍세면 잔다리길 55, 천안시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-30 00:00
Regulatory Filings
투자판단관련주요경영사항
Korean 9.0 KB
2025-07-14 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 14.8 KB
2025-07-14 00:00
Interim / Quarterly Report
반기보고서 (2025.05)
Korean 876.8 KB
2025-04-29 00:00
Regulatory Filings
투자판단관련주요경영사항
Korean 10.4 KB
2025-04-28 00:00
Regulatory Filings
투자판단관련주요경영사항
Korean 8.5 KB
2025-04-14 00:00
Quarterly Report
분기보고서 (2025.02)
Korean 827.4 KB
2025-02-27 00:00
AGM Information
정기주주총회결과
Korean 23.9 KB
2025-02-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.8 KB
2025-02-19 00:00
Audit Report / Information
감사보고서제출
Korean 11.9 KB
2025-02-19 00:00
Audit Report / Information
[첨부추가]사업보고서 (2024.11)
Korean 524.8 KB
2025-02-12 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 15.8 KB
2025-02-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.9 KB
2025-02-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 109.6 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.6 KB
2025-02-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 6.1 KB

Automate Your Workflow. Get a real-time feed of all HYUNDAI PHARMACEUTICAL CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HYUNDAI PHARMACEUTICAL CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HYUNDAI PHARMACEUTICAL CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ALNYLAM PHARMACEUTICALS, INC. Logo
Pioneering RNAi gene-silencing therapies for rare genetic and cardiometabolic diseases.
United States of America
ALNY
Alpha Cognition Inc. Logo
Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.
United States of America
ACOG
Alpha Teknova, Inc. Logo
Manufactures critical reagents for biopharma, scaling from research to GMP manufacturing.
United States of America
TKNO
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Altimmune, Inc. Logo
Developing novel peptide therapeutics for obesity, liver, and cardiometabolic diseases.
United States of America
ALT
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN

Talk to a Data Expert

Have a question? We'll get back to you promptly.